VENTURE FUND - RTW Funds Investments

INVESTOR FINANCIALS

SHARE PRICE

SHARE CHART

CALCULATOR

INVESTOR BULLETIN

RNS & INSIDE INFORMATION

FUND NEWS

JUNE 2020 HALF-YEARLY REPORT AND FINANCIAL STATEMENTS
24/09/2020

ANNUAL RESULTS 2019 PRESENTATION
22/04/2020

ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS 2019
22/04/2020

RTW VENTURE FUND LTD - NET ASSET VALUE(S)
16/12/2019

RTW LEADS $100M FINANCING IN AVIDITY BIOSCIENCES
21/11/2019

HOLDING(S) IN COMPANY
05/11/2019

INVESTOR INFORMATION

Results Center

24 September 2020	Interim Results 2020 Presentation	(2 MB)
24 September 2020	June 2020 Half-Yearly Report and Financial Statements	(2 MB)
22 April 2020	Annual Results 2019 Presentation	(2.13MB)
22 April 2020	Annual Report and Audited Financial Statements 2019	(3.03MB)

DOCUMENT LIBRARY

22 January 2021	Fact Sheet Q4 2020	(446KB)
29 October 2020	Key Information Document	(240KB)
19 October 2020	Fact Sheet Q3 2020	(695KB)
21 July 2020	Fact Sheet Q2 2020	(589KB)
26 June 2020	AGM Shareholder Q&A	(102KB)
29 May 2020	Nomination Remuneration Committee Terms of Reference	(122KB)
29 May 2020	MEC Terms of Reference	(123KB)
21 May 2020	Notice of Annual General Meeting	(600KB)
21 May 2020	Form of Proxy	(583KB)
16 April 2020	Fact Sheet Q1 2020	(538KB)
5 March 2020	Audit Committee Terms of Reference	(97.9KB)
REGULATORY 7 February 2020	Investor Disclosure Document	(154KB)
14 October 2019	GDPR Compliant Privacy Policy	(117KB)
14 October 2019	Launch Announcement	(465KB)
14 October 2019	Prospectus	(2.36MB)
14 October 2019	Prospectus Summary	(276KB)
14 October 2019	Articles of Incorporation	(470KB)

INQUIRIES

INVESTOR & MEDIA INQUIRIES

Stephanie Sirota — Chief Business Officer
T: +1.646.597.6980
E: sas@rtwfunds.com

SHAREHOLDER INQUIRIES

E: RTWVentureFund@rtwfunds.com

Copyright © RTW Investments, LP. All rights reserved.

THIS WEBSITE IS NOT INTENDED TO OFFER OR TO PROMOTE THE OFFER OR SALE OF THE SHARES (THE “SHARES”) OF RTW VENTURE FUND LIMITED (THE “COMPANY”) IN THE UNITED STATES OR TO ANY “U.S. PERSONS” AS DEFINED IN REGULATION S (“US PERSONS”) UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THE MATERIALS CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO ANY PERSONS TO WHOM OR INTO OR WITHIN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW OR REGULATION.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance.The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States or who are US Persons or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.